Hemotune is a Swiss medical device startup with a mission to combat sepsis through magnetic blood purification. Founded in 2016 and a member of @Wyss Zurich, the company is dedicated to developing life-saving therapies. Their focus lies in translating promising research into clinical applications, ensuring patient access to scientific progress, and prioritizing patients' needs. Their recent Fr.14.00M Series B investment on 25 March 2024 involved participation from key investors like Occident, VP Venture Partners, EFI Lake Geneva Ventures, Hemex, Belmondo, and Zürcher Kantonal Bank. Hemotune's primary emphasis is to address sepsis, a lethal condition causing millions of deaths annually. This reflects their pioneering spirit, courage in decision-making, and commitment to shaping the future of medicine.
hemotune AG
We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich.
Schlieren, Switzerland
25 employees
Series B
Total: $31.28M
Biotechnology, Health Care +3
General Information
Schlieren, Switzerland
BounceWatch is an independent company data service, not affiliated with hemotune AG. To contact hemotune AG, visit hemotune.ch.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Switzerland Market
Biotechnology
About hemotune AG
Taxonomy: Blood Purification, Nanotechnology, Sepsis Treatment, Life-saving Therapies, Research Translation, Clinical Innovation, Patient Access, ETH Zurich Spinoff, Innovative Medical Technology, Swiss Company, Wyss Zurich Member, Breakthrough Medical Device, Future of Medicine
Funding Rounds & Investors (14)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | Fr.14.00M | 6 |
|
25 Mar 2024 |
| Grant | Undisclosed | 1 |
|
28 Apr 2023 |
| Series B | Fr.7.25M | 4 |
|
26 Apr 2022 |
| Grant | Undisclosed | 1 |
|
09 Mar 2022 |
| Series A | Fr.5.10M | 2 |
|
14 Aug 2020 |
| Grant | €500.00K | 1 |
EIT Health
|
09 Jul 2020 |
| Grant | Fr.525.00K | 1 |
|
01 Feb 2020 |
| Grant | €280.00K | 2 |
Eurostars, EASME - EU Executive Agency for SMEs
|
19 Mar 2019 |
| Grant | €50.00K | 1 |
H2020-SME-Instrument program
|
01 Dec 2018 |
| Seed Round | Fr.100.00K | 1 |
|
21 Jun 2017 |
hemotune AG Alternatives & Competitors
View All Alternatives
A cardiac medical device company determined to improve the lives of heart failure patients through C...
Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections...
Crafting novel therapies to enhance the length and quality of life for seriously ill patients worldw...
FAQ About hemotune AG
Source: BounceWatch company record for hemotune AG, https://bouncewatch.com/company/hemotune, updated 29 December 2024. When citing, please name BounceWatch and link this page.
